Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Danchin

Showing results (1-10 of 431) with videos related to

Pageof 44
Sort By:
La Revue Du Praticien|December 21, 2005
[Cardiovascular risk factors: on which elements to base the actions of prevention?]Nicolas Danchin
Heart (British Cardiac Society)|November 26, 2009
C-reactive protein for risk assessment in coronary artery diseaseNicolas Danchin
Therapie|August 12, 2009
Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trialNicolas Danchin
Circulation|May 23, 2007
A view from Paris: Nicolas Danchin, MD, FESC. Interview by Robert ShortNicolas Danchin
Indian Heart Journal|May 13, 2014
Letter to the editor for sponsored article "pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian registry" by Iyengar et alNicolas Danchin
La Revue Du Praticien|May 29, 2015
[Natural history of coronary artery disease]Nicolas Danchin
La Revue Du Praticien|August 22, 2002
[Curietherapy (brachytherapy) in restenosis following coronary angioplasty: panacea or sorcerer's apprentice technique?]Nicolas Danchin
Archives of Cardiovascular Diseases|April 19, 2011
The virtues of observational medicine. Lessons from the French Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) registryNicolas Danchin
European Journal of Preventive Cardiology|January 13, 2026
Lipid management after an acute coronary syndrome: reasons to hope, reasons to persistNicolas Danchin
European Heart Journal|October 1, 2010
Winning the battle against ST-segment-elevation myocardial infarction: continued progress, but still a long way to goNicolas Danchin
Pageof 44

Showing results (1-10 of 431) with videos related to

Sort By:
Pageof 44
La Revue Du Praticien|December 21, 2005
[Cardiovascular risk factors: on which elements to base the actions of prevention?]Nicolas Danchin
Heart (British Cardiac Society)|November 26, 2009
C-reactive protein for risk assessment in coronary artery diseaseNicolas Danchin
Therapie|August 12, 2009
Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trialNicolas Danchin
Circulation|May 23, 2007
A view from Paris: Nicolas Danchin, MD, FESC. Interview by Robert ShortNicolas Danchin
Indian Heart Journal|May 13, 2014
Letter to the editor for sponsored article "pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian registry" by Iyengar et alNicolas Danchin
La Revue Du Praticien|May 29, 2015
[Natural history of coronary artery disease]Nicolas Danchin
La Revue Du Praticien|August 22, 2002
[Curietherapy (brachytherapy) in restenosis following coronary angioplasty: panacea or sorcerer's apprentice technique?]Nicolas Danchin
Archives of Cardiovascular Diseases|April 19, 2011
The virtues of observational medicine. Lessons from the French Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) registryNicolas Danchin
European Journal of Preventive Cardiology|January 13, 2026
Lipid management after an acute coronary syndrome: reasons to hope, reasons to persistNicolas Danchin
European Heart Journal|October 1, 2010
Winning the battle against ST-segment-elevation myocardial infarction: continued progress, but still a long way to goNicolas Danchin
Pageof 44